Abstract
This chapter describes the detailed steps for a standard total mesorectal excision (TME) as applied during low anterior resection (LAR) for rectal cancer. The extent and approach (open versus minimally invasive) chosen for the resection may vary depending on the specifics (e.g., size) and the exact location of the target pathology (upper, middle, or lower third of the rectum). Multimodality treatment and possibly the presence of underlying risk constellations (hereditary cancer, inflammatory bowel disease) may affect the decision-making. This chapter includes information on indications, pitfalls and danger points, preoperative preparation, postoperative care, and complications. Detailed operative strategy and technique are included.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Further Reading
American Medical Association. Current procedural terminology: CPT ®. Professional ed. Chicago: American Medical Association; 2022. https://www.ama-assn.org/practice-management/cpt.
Bonjer HJ, Deijen CL, et al. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med. 2015;372(14):1324–32.
Celentano V, Ausobsky JR, et al. Surgical management of presacral bleeding. Ann R Coll Surg Engl. 2014;96(4):261–5.
Fleshman J, Branda M, et al. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA. 2015;314(13):1346–55.
How P, Shihab O, et al. A systematic review of cancer related patient outcomes after anterior resection and abdominoperineal excision for rectal cancer in the total mesorectal excision era. Surg Oncol. 2011;20(4):e149–55.
Monson JR, Weiser MR, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum. 2013;56(5):535–50.
Patel UB, Taylor F, et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol. 2011;29(28):3753–60.
Peeters KC, Marijnen CA, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246(5):693–701.
Stevenson AR, Solomon MJ, et al. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA. 2015;314(13):1356–63.
Taylor FG, Quirke P, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011;253(4):711–9.
van Gijn W, Marijnen CA, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12(6):575–82.
Vennix S, Pelzers L, et al. Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst Rev. 2014;4:CD005200.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cologne, K.G., Senagore, A.J., Kaiser, A.M. (2022). Total Mesorectal Excision/Low Anterior Resection (Open, Laparoscopic). In: Scott-Conner, C.E.H., Kaiser, A.M., Nguyen, N.T., Sarpel, U., Sugg, S.L. (eds) Chassin's Operative Strategy in General Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-81415-1_59
Download citation
DOI: https://doi.org/10.1007/978-3-030-81415-1_59
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-81414-4
Online ISBN: 978-3-030-81415-1
eBook Packages: MedicineMedicine (R0)